134 related articles for article (PubMed ID: 22918079)
1. Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells.
Cheng TM; Murad YM; Chang CC; Yang MC; Baral TN; Cowan A; Tseng SH; Wong A; Mackenzie R; Shieh DB; Zhang J
Eur J Cancer; 2014 Mar; 50(4):713-21. PubMed ID: 22918079
[TBL] [Abstract][Full Text] [Related]
2. Molecular targeting of CEACAM6 using antibody probes of different sizes.
Niu G; Murad YM; Gao H; Hu S; Guo N; Jacobson O; Nguyen TD; Zhang J; Chen X
J Control Release; 2012 Jul; 161(1):18-24. PubMed ID: 22568933
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
Blumenthal RD; Hansen HJ; Goldenberg DM
Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051
[TBL] [Abstract][Full Text] [Related]
4. Isolation of functional single domain antibody by whole cell immunization: implications for cancer treatment.
Baral TN; Murad Y; Nguyen TD; Iqbal U; Zhang J
J Immunol Methods; 2011 Aug; 371(1-2):70-80. PubMed ID: 21741385
[TBL] [Abstract][Full Text] [Related]
5. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
[TBL] [Abstract][Full Text] [Related]
6. Single-domain antibody bioconjugated near-IR quantum dots for targeted cellular imaging of pancreatic cancer.
Zaman MB; Baral TN; Jakubek ZJ; Zhang J; Wu X; Lai E; Whitfield D; Yu K
J Nanosci Nanotechnol; 2011 May; 11(5):3757-63. PubMed ID: 21780366
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.
Chiang WF; Cheng TM; Chang CC; Pan SH; Changou CA; Chang TH; Lee KH; Wu SY; Chen YF; Chuang KH; Shieh DB; Chen YL; Tu CC; Tsui WL; Wu MH
Oncogene; 2018 Jan; 37(1):116-127. PubMed ID: 28892050
[TBL] [Abstract][Full Text] [Related]
8. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma.
Strickland LA; Ross J; Williams S; Ross S; Romero M; Spencer S; Erickson R; Sutcliffe J; Verbeke C; Polakis P; van Bruggen N; Koeppen H
J Pathol; 2009 Jul; 218(3):380-90. PubMed ID: 19334050
[TBL] [Abstract][Full Text] [Related]
10. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
11. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012
[TBL] [Abstract][Full Text] [Related]
12. Cell motility and spreading promoted by CEACAM6 through cyclin D1/CDK4 in human pancreatic carcinoma.
Yan L; Wang Y; Wang ZZ; Rong YT; Chen LL; Li Q; Liu T; Chen YH; Li YD; Huang ZH; Peng J
Oncol Rep; 2016 Jan; 35(1):418-26. PubMed ID: 26497080
[TBL] [Abstract][Full Text] [Related]
13. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE
Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794
[TBL] [Abstract][Full Text] [Related]
14. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
15. Generation of Rat Monoclonal Antibodies Against Human Pancreatic Ductal Adenocarcinoma Cells.
Higashi K; Fujii N; Kushida M; Yamada K; Suzuki N; Saito K; Tachibana T
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):148-54. PubMed ID: 27172290
[TBL] [Abstract][Full Text] [Related]
16. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
Duxbury MS; Ito H; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Apr; 317(1):133-41. PubMed ID: 15047158
[TBL] [Abstract][Full Text] [Related]
17. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression.
Cui P; Yu M; Peng X; Dong L; Yang Z
J Pineal Res; 2012 Mar; 52(2):236-43. PubMed ID: 21913973
[TBL] [Abstract][Full Text] [Related]
18. CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer.
Zhang Y; Zang M; Li J; Ji J; Zhang J; Liu X; Qu Y; Su L; Li C; Yu Y; Zhu Z; Liu B; Yan M
Acta Biochim Biophys Sin (Shanghai); 2014 Apr; 46(4):283-90. PubMed ID: 24492534
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity.
Hong KP; Shin MH; Yoon S; Ji GY; Moon YR; Lee OJ; Choi SY; Lee YM; Koo JH; Lee HC; Lee GK; Kim SR; Lee KH; Han HS; Choe KH; Lee KM; Hong JM; Kim SW; Yi JH; Ji HJ; Kim YB; Song HG
Biomaterials; 2015 Oct; 67():32-41. PubMed ID: 26204223
[TBL] [Abstract][Full Text] [Related]
20. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer.
Chen J; Li Q; An Y; Lv N; Xue X; Wei J; Jiang K; Wu J; Gao W; Qian Z; Dai C; Xu Z; Miao Y
Int J Oncol; 2013 Sep; 43(3):877-85. PubMed ID: 23857344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
